Through their ability to modulate the TIME by inhibiting inflammatory cascades, PD-L1 and CCL2 expression, reducing immune-suppressive cells and metastasis, and inhibiting the recruitment of pro-tumorigenic immune cells, as well as other cancer development processes, polyphenols offer potential avenues for combating TNBC aggressiveness and improving patient outcomes. Here, CCL2 is linked to cancer.